G
Gary V. Martin
Researcher at University of Washington
Publications - 23
Citations - 1197
Gary V. Martin is an academic researcher from University of Washington. The author has contributed to research in topics: Myocardial infarction & Coronary occlusion. The author has an hindex of 13, co-authored 23 publications receiving 1156 citations. Previous affiliations of Gary V. Martin include United States Department of Veterans Affairs & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Effect of chronic total coronary occlusion on treatment strategy.
Ryan D. Christofferson,Kenneth G. Lehmann,Gary V. Martin,Nathan R. Every,James H. Caldwell,Samir R. Kapadia +5 more
TL;DR: In a multivariate analysis, CTO was the strongest predictor against the selection of percutaneous coronary intervention (PCI) as a treatment strategy, indicating that efforts to improve the success rate of PCI in CTO may have a significant impact on management of coronary disease.
Journal ArticleDOI
The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.
J W Kennedy,Gary V. Martin,Kathryn B. Davis,Charles Maynard,Michael L. Stadius,Florence H. Sheehan,James L. Ritchie +6 more
TL;DR: It is concluded that patients with anterior myocardial infarction have improved survival when treated within the first 6 hr of symptoms, and patients with inferior infarctions do not appear to haveImproved survival with thrombolytic therapy.
Journal Article
Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography.
Gary V. Martin,James H. Caldwell,Michael M. Graham,John R. Grierson,Keith Kroll,Marie J. Cowan,Thomas K. Lewellen,Janet S. Rasey,Joseph J. Casciari,Kenneth A. Krohn +9 more
TL;DR: PET imaging of [18F]FMISO is a promising technique for the noninvasive identification of viable hypoxic myocardium non-invasively using positron emission tomography (PET).
Journal Article
Enhanced Binding of the Hypoxic Cell Marker [3H]Fluoromisonidazole in Ischemic Myocardium
Gary V. Martin,James H. Caldwell,Janet S. Rasey,Zdenka Grunbaum,Manuel D. Cerqueira,Kenneth A. Krohn +5 more
TL;DR: Plasma clearance data indicate the drug is rapidly distributed into the total-body water, clears from the body with a half-life of 275 +/- 50 min, and undergoes minimal metabolism by 4 hr, concluding [18F]fluoromisonidazole may be a suitable agent for radionuclide imaging of hypoxic myocardium.
Journal ArticleDOI
Regional myocardial flow and capillary permeability-surface area products are nearly proportional
TL;DR: The method was to estimate both flow and capillary membrane permeability-surface area products (PS) locally in the heart to take into account the near proportionality of PS to flow for at least some substrates.